Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03307317 · ClinicalTrials.gov registry record

Mirror Neuron Network Dysfunction as an Early Biomarker of Neurodevelopmental Disorder

A clinical trial of Developmental Delay, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

Recruiting
Registry status
200
Enrollment target
1
Study location

NCT03307317: Recruiting study of Developmental Delay, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

NCT03307317 is a study of Developmental Delay that is actively recruiting participants, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 200 participants, below the 277-participant average among 10 other Developmental Delay trials with a reported enrollment target (28% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03307317, a study of Developmental Delay, is actively recruiting participants, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

RECRUITING
Registry status
200 participants
Enrollment target
1
Study location

Study Summary

Background: People show changes in brain activity when they watch other people do actions. This may be part of early social and communication skills. Researchers want to understand the stages of normal development of motor observation and imitation in people and how it relates to social development in infants and toddlers. Objective: To study the nature of brain activity that underlies typical brain functioning in infants, toddlers, and adults. Eligibility: Infants ages 8 12 months Healthy adults ages 18 65 Design: Adult participants will have one visit. They will: Answer questions about their family, like its size and ethnicity. Answer questions about their own behavior and do a simple motor task. Have EEG/fNIRS. A damp elastic cap with small sensors will be placed on the head. Participants will observe stimuli, either on a video screen or of a live person. The sensors will be connected to a computer. That will record the participant s brain activity while watching pictures on a screen. Infant participants will have 2 visits. Their parents will answer questions about their family. The parents will fill out forms about their child s development. These will be mailed to them before each visit. Parents will stay with their infant while study staff does an assessment of the child s communication, motor, and thinking skills. Infants will have EEG/fNIRS. Infants who are at risk for developmental delays will come back for another visit when they are about 2 years old. This will repeat the infant visits but it will not include EEG/fNIRS. Some questionnaires and assessments will be videotaped.

Primary Outcome

Diagnostic status and behavioral scales that reflect child development at different levels: gross motor, fine motor, language and visual reception.

Conditions Studied

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2018-08-30
Est. Completion 2031-02-01

What NCT03307317 shows while recruiting

NCT03307317 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 277-participant average among 10 other Developmental Delay trials with a reported enrollment target (28% lower).

The record links to 1 condition, with Developmental Delay appearing as the primary indexed condition, and to 0 interventions.

NCT03307317 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT03307317 about?

NCT03307317 is a clinical study titled "Mirror Neuron Network Dysfunction as an Early Biomarker of Neurodevelopmental Disorder". Background: People show changes in brain activity when they watch other people do actions. This may be part of early social and communication skills. Researchers want to understand the stages of normal development of motor observation and imitation in people and how it relates to social development...

What is the current status of trial NCT03307317?

This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2018-08-30. Estimated completion is 2031-02-01.

What conditions does trial NCT03307317 study?

This clinical trial studies the following conditions: Developmental Delay.

Who is sponsoring clinical trial NCT03307317?

This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03307317 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Developmental Delay

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03307317's enrollment target sits among peer trials

200 7th of 10 higher than 4 of 10 other Developmental Delay trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Developmental Delay trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03307317, the US trial registry maintained by the National Library of Medicine. NCT03307317 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.